I am sure that all of Europe's problems do not stem from the recent immigration flood. However, HIV and AIDS high infection rates, and lack of testing, can be (partially) attributed to the flood of illegal immigration from sub-Sahara Africa.

Europe, and Africa, could be strong markets for Leronlimab.

https://www.sciencedirect.com/science/article...1822000327


https://bmcpublichealth.biomedcentral.com/art...015-2571-y


https://apha.confex.com/apha/2017/meetingapp....per/386886